Table 2.
Number and Percent of Self-Reported Sleep Aid Use by Category at Each Measurement Timea During and Following Chemotherapya,b
| Time | Rx Sedative/ Hypnotic |
Rx Anti- Depressant |
Rx Analgesic |
Rx Anti- Emetic |
OTC Analgesic |
OTC cold/flu/ sinus |
OTC sleep |
Alcoholic Beverages |
Herbals | Total Sleep Aids taken (% of 3018) |
|---|---|---|---|---|---|---|---|---|---|---|
| CTX1 (n=203) | 140 (42%) | 3 (0.8%) | 30 (9%) | 22 (6%) | 88 (26%) | 19 (6%) | 21 (6%) | 12 (4%) | 1 (0.2%) | 336 (11%) |
| CTX2 (n=188) | 198 (56%) | 1 (0.2%) | 28 (8%) | 3 (0.8%) | 73 (21%) | 35 (10%) | 8 (2%) | 9 (2%) | 0 (0%) | 355 (12%) |
| CTX3 (n=189) | 191 (51%) | 0 (0%) | 30 (8%) | 0 (0%) | 96 (26%) | 29 (8%) | 16 (4%) | 8 (2%) | 2 (1%) | 372 (12%) |
| CTX4 (n= 180) | 189 (49%) | 0 (0%) | 27 (7%) | 1 (0.2%) | 97 (25%) | 31 (8%) | 24 (6%) | 13 (4%) | 3 (0.8%) | 385 (13%) |
| CTX5b (n=112) | 101 (46%) | 9 (4%) | 4 (2%) | 0 (0%) | 59 (27%) | 29 (13%) | 10 (5%) | 6 (2%) | 1 (1%) | 219 (7%) |
| CTX6b (n=110) | 95 (46%) | 9 (4%) | 7 (3%) | 0 (0%) | 50 (24%) | 25 (12%) | 11 (5%) | 10 (5%) | 1 (1%) | 208 (7%) |
| CTX7b (n=93) | 96 (49%) | 9 (5%) | 12 (6%) | 0 (0%) | 40 (20%) | 19 (9%) | 11 (6%) | 9 (5%) | 0 (0%) | 196 (7%) |
| CTX8b (n=88) | 74 (40%) | 0 (0%) | 6 (3%) | 0 (0%) | 47 (26%) | 30 (16%) | 13 (7%) | 10 (5%) | 6 (3%) | 186 (6%) |
| 30 days (n= 182) | 96 (46%) | 0 (0%) | 24 (12%) | 0 (0%) | 52 (25%) | 15 (7%) | 12 (6%) | 8 (3%) | 1 (1%) | 208 (7%) |
| 60 days (n= 181) | 81 (39%) | 0 (0%) | 14 (7%) | 0 (0%) | 52 (25%) | 26 (12%) | 12 (6%) | 16 (7%) | 9 (4%) | 210 (7%) |
| 90 days (n= 178) | 74 (39%) | 7 (4%) | 13 (7%) | 0 (0%) | 37 (20%) | 39 (21%) | 8 (4%) | 10 (5%) | 0 (0%) | 188 (6%) |
| 1 Year (n=173) | 60 (39%) | 0 (0%) | 8 (5%) | 0 (0%) | 25 (16%) | 37 (24%) | 7 (4%) | 14 (9%) | 4 (3%) | 155 (5%) |
| Total | 1395** (46%)c | 38 (1%)c | 203 (7%)c | 26 (1%)c | 716* (24%)c | 334 (11%)c | 153 (5%)c | 125 (4%)c | 28 (1%)c | 3018 |
a
9 nights total for each CTX (2 nights before & 7 nights during CTX); 7 nights total at 30, 60, & 90 days following the last CTX; 7 nights total 1 year following CTX1
b
shaded area denotes participants with taxanes.
c
% out of total sleep aids used (3018)
*
Wilks’ Lambda Test for RM-ANOVA (CTX1-CTX4,30,60,90,1year) significant at p<0.05
**
Wilks’ Lambda Test for RM-ANOVA (CTX1-CTX4,30,60,90,1year) significant at p<0.01